Free Trial

Justice Department and four Attorneys General block $3.3 billion acquisition of Amedisys Inc. 

The Justice Department and four Attorneys General have blocked UnitedHealth Group Incorporated’s $3.3 billion acquisition of Amedisys Inc.

The Attorneys General of Maryland, Illinois, New Jersey, and New York joined the blockade alongside the legal watchdog of the United States government, saying that the deal threatens to “negatively affect care for vulnerable patients and harm home health and hospice nurses critical to providing that care.”

“We are challenging this merger because home health and hospice patients and their families experiencing some of the most difficult moments of their lives deserve affordable, high-quality care options,” said Attorney General Merrick B. Garland

UnitedHealth Group Incorporated’s $3.3 billion acquisition of Amedisys Inc. blocked

The bodies filed the civil antitrust lawsuit in the District of Maryland, alleging that the transaction would eliminate competition between UnitedHealth and Amedisys, two titans in the United States market for home healthcare.

UnitedHealth acquired LHC Group Inc. (LHC) in 2023, one of the then largest competitors to UnitedHealth and Amedisys. A similar move to take over Amedisys would further dilute the competition amongst nursing staff, health services, and insurers nationwide.

“American healthcare is unwell. Unless this $3.3 billion transaction is stopped, UnitedHealth Group will further extend its grip to home health and hospice care, threatening seniors, their families and nurses,” said Assistant Attorney General Jonathan Kanter of the Justice Department’s Antitrust Division. “I want to thank my colleagues at the Antitrust Division for their tireless efforts to fight on behalf of Americans for a competitive economy.”

A former CEO and current Board Chairman of Amedisys has acknowledged in the details of the complaint that the “pure competition” between UnitedHealth and Amedisys helps them “keep each other honest” and “driv[e] better and better quality” to the benefit of their patients.”

One of the major concerns for the legal regulators and Attorneys General involved is UnitedHealth’s projected market share of the current healthcare market post-merger. The complainers against the deal say this would be “presumptively illegal.”

The Justice Department is concerned that the merger fails to protect the interests of “100 home health, hospice, and labor markets, which generate at least a billion dollars in revenue annually, serve at least 200,000 patients, and employ at least 4,000 nurses.”

It remains to be seen whether the measures taken by the complainers will prevail, but regardless of the result, their efforts will define the future of the healthcare market across America.

Image: Pixlr.

The post Justice Department and four Attorneys General block $3.3 billion acquisition of Amedisys Inc.  appeared first on Due.

→ 24/7 Automated Profits in Crypto (From Crypto Swap Profits) (Ad)

Should you invest $1,000 in Amedisys right now?

Before you consider Amedisys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amedisys wasn't on the list.

While Amedisys currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Amedisys (AMED)
3.8892 of 5 stars
$90.05-0.3%N/A35.73Hold$100.67
LHC Group (LHCG)N/A$169.81+0.5%N/A82.83N/AN/A
UnitedHealth Group (UNH)
4.9309 of 5 stars
$592.23-0.2%1.42%38.58Moderate Buy$615.53
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Recent Videos

Why Whitestone REIT is Outperforming in 2024: 35% Growth & Monthly Dividends
Why SoundHound Stock Dip Could Mean Big Gains for 2025 Investors
Nintendo Stock: Buy Before the 2025 Switch Platform Hits!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines